Report September 2009: Difference between revisions

From Commons Based Research
Jump to navigation Jump to search
Line 8: Line 8:
*We are developing a better understanding of the intellectual property landscape and have established that a wide variety of protections are used including: patent, trade secrets, NDAs, Non-compete, non-solicitation, confidentiality agreements. [[Overview_of_Economics_of_Intellectual_Property_in_Kits|Economics of IP]] & [[IP_in_Kits|IP]]
*We are developing a better understanding of the intellectual property landscape and have established that a wide variety of protections are used including: patent, trade secrets, NDAs, Non-compete, non-solicitation, confidentiality agreements. [[Overview_of_Economics_of_Intellectual_Property_in_Kits|Economics of IP]] & [[IP_in_Kits|IP]]
**There has been "an increase in patents on the inputs to drug discovery (“research tools”)." (Cohen et. al., 2003)
**There has been "an increase in patents on the inputs to drug discovery (“research tools”)." (Cohen et. al., 2003)
***no substantially barriers have been found as a result of this increase in patents on the inputs to drug discovery
***no substantially barriers have been found as a result of this increase in patents on the inputs to drug discovery (Cohen et. al., 2003)
***no substantially barriers found to university research
***no substantially barriers found to university research (Cohen et. al., 2003)
***THE EXCEPTION: "Restrictions on the use of patented genetic diagnostics, where we see some evidence of patents interfering with university research, are an important exception. There is, also, some evidence of delays associated with negotiating access to patented research tools, and there are areas in which patents over targets limit access and where access to foundational discoveries can be restricted. There are also cases in which research is redirected to areas with more intellectual property (IP) freedom. Still, the vast majority of respondents say that there are no cases in which valuable research projects were stopped because of IP problems relating to research inputs." (Cohen et. al., 2003)
***THE EXCEPTION: "Restrictions on the use of patented genetic diagnostics, where we see some evidence of patents interfering with university research, are an important exception. There is, also, some evidence of delays associated with negotiating access to patented research tools, and there are areas in which patents over targets limit access and where access to foundational discoveries can be restricted. There are also cases in which research is redirected to areas with more intellectual property (IP) freedom. Still, the vast majority of respondents say that there are no cases in which valuable research projects were stopped because of IP problems relating to research inputs." (Cohen et. al., 2003)
*No open business models have emerged in the literature or through interviews.
*No open business models have emerged in the literature or through interviews.

Revision as of 16:44, 24 September 2009

Status Report, ICP Project

Diagnostic Kits

General Status

  • He have created a glossary of research vocabulary that has a allowed us to better define the field.
  • We have developed a bibliography with literary reviews of the key articles.
    • We have found that genetic diagnostic kits are probably best suited for this study
  • We are developing a better understanding of the intellectual property landscape and have established that a wide variety of protections are used including: patent, trade secrets, NDAs, Non-compete, non-solicitation, confidentiality agreements. Economics of IP & IP
    • There has been "an increase in patents on the inputs to drug discovery (“research tools”)." (Cohen et. al., 2003)
      • no substantially barriers have been found as a result of this increase in patents on the inputs to drug discovery (Cohen et. al., 2003)
      • no substantially barriers found to university research (Cohen et. al., 2003)
      • THE EXCEPTION: "Restrictions on the use of patented genetic diagnostics, where we see some evidence of patents interfering with university research, are an important exception. There is, also, some evidence of delays associated with negotiating access to patented research tools, and there are areas in which patents over targets limit access and where access to foundational discoveries can be restricted. There are also cases in which research is redirected to areas with more intellectual property (IP) freedom. Still, the vast majority of respondents say that there are no cases in which valuable research projects were stopped because of IP problems relating to research inputs." (Cohen et. al., 2003)
  • No open business models have emerged in the literature or through interviews.
  • We recently addresses the organizational needs of the paper in a few ways

Work Completed

Work Partially Completed

Work Remaining

Research Methodology in use

  • Case studies
  • Literature review
  • Industry analysis
  • Business reports and press releases
  • University reports and press releases

Problems and Considerations

  • How can we learn more about the use of trade secret protection of data?
  • What information should we aim to obtain through interviews?
  • Should we focus on genetic diagnostic tests exclusively?

Next Steps

  • Continue to add information to the research methodology. Specifically, increase information about University contributions.
  • Continue to interview experts in the field